Clinical

Dataset Information

0

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors


ABSTRACT: Urinary measure of 5-hydroxyindolacetic acid (5HIAA) is an important marker for the diagnosis and follow-up of patients with small-intestine neuroendocrine tumors. Although this marker has good specificity, its sensitivity is moderate and its dosage is constraining, since it requires urine collection over 2-3 days and specific diet. Preliminary data suggested that overnight 5HIAA value may be representative of 24-hour 5HIAA value, and that plasma 5HIAA dosage could be a valuable alternative to urine 5HIAA dosage. The main objective of this study is to compare sensitivity and specificity of overnight 5HIAA value, 24-hour 5HIAA value and plasma 5HIAA value, in patients with small-intestine neuroendocrine tumors.

DISEASE(S): Neuroendocrine Tumors,Carcinoid Tumor,Small-intestine Neuroendocrine Tumors (carcinoid Tumors)

PROVIDER: 2219336 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2016-06-01 | E-GEOD-79017 | biostudies-arrayexpress
| 2739807 | ecrin-mdr-crc
2020-06-30 | GSE153431 | GEO
2021-02-02 | GSE157640 | GEO
2016-06-01 | GSE79017 | GEO
2019-11-04 | GSE104496 | GEO
2012-07-28 | GSE39707 | GEO
2006-09-09 | GSE5768 | GEO
2018-09-27 | GSE87381 | GEO
2019-01-23 | GSE125442 | GEO